grab the latest..
Whitepapers
Narcolepsy Type 1 (NT1)
Narcolepsy is a chronic neurological disorder that affects the brain’s ability to control sleep-wake cycles
Narcolepsy type 1 (NT1) is a sleep disorder characterized by an overwhelming tendency for excessive daytime sleepiness (EDS), episodes of cataplexy and abnormalities in rapid eye movement sleep
Hallmark symptom of NT1: Cataplexy
LIFE CYCLE MANAGEMENT STRATEGY (LCMS)
Life cycle management strategy (LCMS) is a systematic approach used by pharmaceutical companies
THYROID EYE DISEASE
It is an autoimmune condition in which the immune system mistakenly attacks the muscles and fatty tissues behind the eyes.
Beta Thalassemia
Beta thalassemia is an autosomal recessive blood disorder caused by mutations in the HBB gene on chromosome 11
Obesity Treatment
Obesity is a chronic disease associated with a broad spectrum of metabolic, biomechanical and psychosocial complications that emerge across the lifespan.
Human Babesiosis Disease
Babesiosis is an infectious disease caused by the apicomplexan parasites of the genus Babesia, which infect and destroy red blood cells (RBC)
Latest whitepapers
An emerging class of therapies but facing setbacks
An emerging class of therapies but facing setbacks
2023 insights into Swissmedic authorization of human medicinal products featuring a new active substance and additional indications
2023 Highlights of European Medicines Agency's human medications recommendations.
What's in store for 2024?
Do these data change practice?
Practice changing or more of the same
Discover the process of development, manufacturing, and mitigation of challenges associated with mRNA vaccines
Upcoming Papers
To receive an early preview, register with us.
To receive an early preview, register with us.
To receive an early preview, register with us.
To receive an early preview, register with us.
To receive an early preview, register with us.